期刊文献+

MR-proADM对慢性心力衰竭的诊断及预后评估价值 被引量:13

The diagnostic and prognostic value of MR-proADM levels in patients with chronic heart failure
原文传递
导出
摘要 目的:研究肾上腺髓质中段肽(MR-proADM)水平对慢性心力衰竭(心衰)的诊断及预后评估价值。方法:随机入选330例慢性心衰患者,同期选择健康体检者90例作为健康对照组。各组入组后24h内及症状缓解后7d均测定N末端脑钠肽前体(NT-proBNP)、MR-proADM、心脏超声(左心室内径及左心室射血分数)等,追踪随访6个月,以心衰再入院及全因死亡为终点,分为事件组与非事件组,分析MR-proADM对慢性心衰的诊断及预后评估价值。结果:与健康对照组相比,慢性心衰患者的MR-proADM水平明显升高(P<0.05);MR-proADM水平随着心衰病情加重而升高,经药物治疗后下降,且与NT-proBNP水平有显著正相关。多元逐步回归分析显示,MR-proADM、NT-proBNP、左心室射血分数是慢性心衰患者心衰再入院及病死率的独立预测因素。ROC分析的最佳MR-proADM切点为646.31pmol/L。结论:MR-proADM水平对慢性心衰患者的诊断及预后评估有重要的指导意义。 Objective: To study the diagnostic and prognostic value of MR-proADM levels in patients with chronic heart fallure. Method: A total of 330 patients with chronic heart failure were randomly selected, and 90 healthy cases were selected as controls. Within 24 hours after entry of the group and 7 days after remission of symptoms, NT-proBNP, MR-proADM and cardiac ultrasound (left ventricular diameter and left ventricular ejection function) were measured. All the patients were followed up for 6 months, and then divided into event group and non event group according to heart fail- ure readmission and all-cause mortality. The differences of MR-proADM and NT-proBNP were compared and the value of MR-proADM in diagnosis and prognosis of chronic heart failure was evaluated. Result: The level of MR-proADM in patients with chronic heart failure was significantly higher than that in the control group (P〈0.05). The level of MR- proADM was increased with the aggravation of heart failure, and then decreased after drug treatment, MR-proADM lev els were significantly positively correlated with NT-proBNP levels. Stepwise regression analysis showed that, MR- proADM, NT- proBNP and eft ventrieular ejection function were independent predictors of readmission rate and mortality in patients with chronic heart failure, The ROC analysis showed that the cut point of MR-proADM was 646.31 pmol/L. Conclusion: MR-proADM level has important guiding significance in the diagnosis and prognosis evaluation of chronic heart failure.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2017年第5期435-438,共4页 Journal of Clinical Cardiology
基金 上海市卫生和计划生育委员会面上项目(No:201440600)
关键词 心力衰竭 慢性 肾上腺髓质中段肽 诊断 预后评估 chronic heart failure MR-proADM diagnosis prognosis evaluation
作者简介 通信作者:杜国峰,E-mail:qingfeng—zm81@163.com
  • 相关文献

参考文献1

二级参考文献42

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
  • 10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.

共引文献3716

同被引文献100

引证文献13

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部